CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
8.15
-0.39 (-4.57%)
At close: Oct 10, 2025, 4:00 PM EDT
8.10
-0.05 (-0.61%)
After-hours: Oct 10, 2025, 7:36 PM EDT
CervoMed Stock Forecast
Stock Price Forecast
The 6 analysts that cover CervoMed stock have a consensus rating of "Strong Buy" and an average price target of $19.17, which forecasts a 135.21% increase in the stock price over the next year. The lowest target is $11 and the highest is $31.
Price Target: $19.17 (+135.21%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 8, 2025.
Analyst Ratings
The average analyst rating for CervoMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $11 | Hold | Reiterates | $11 | +34.97% | Sep 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $15 → $31 | Strong Buy | Maintains | $15 → $31 | +280.37% | Aug 18, 2025 |
| Roth Capital | Roth Capital | Strong Buy Reiterates $20 → $16 | Strong Buy | Reiterates | $20 → $16 | +96.32% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +84.05% | Aug 11, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 → $15 | Strong Buy | Maintains | $10 → $15 | +84.05% | Aug 11, 2025 |
Financial Forecast
Revenue This Year
6.55M
from 9.74M
Decreased by -32.75%
Revenue Next Year
816.00K
from 6.55M
Decreased by -87.54%
EPS This Year
-2.36
from -2.02
EPS Next Year
-2.21
from -2.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.2M | 5.0M | |||
| Avg | 6.5M | 816,000 | |||
| Low | 4.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.3% | -23.0% | |||
| Avg | -32.7% | -87.5% | |||
| Low | -58.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.45 | -0.61 | |||
| Avg | -2.36 | -2.21 | |||
| Low | -2.55 | -3.48 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.